Suppr超能文献

哮喘炎症的消退。

Resolution of inflammation in asthma.

机构信息

Harvard Medical School, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Clin Chest Med. 2012 Sep;33(3):559-70. doi: 10.1016/j.ccm.2012.06.006. Epub 2012 Jul 25.

Abstract

The resolution of inflammation in healthy airways is an active process, with specialized mediators and cellular mechanisms enlisted to restore tissue homeostasis. This article focuses on recent discoveries of natural mediators derived from essential fatty acids, including ω-3 fatty acids, with anti-inflammatory and pro-resolving. These pro-resolving mediators serve as agonists at specific receptors. Asthma is an incurable disease of chronic, nonresolving inflammation of the airways. While the biosynthesis of pro-resolving mediators occurs during asthma, defects in their production are associated with disease severity, suggesting that the pathobiology of asthma may result in part from impaired resolution of airway inflammation.

摘要

健康气道的炎症消退是一个主动的过程,其中专门的介质和细胞机制被募集来恢复组织的内稳态。本文主要关注从必需脂肪酸(包括 ω-3 脂肪酸)衍生的天然介质的最新发现,它们具有抗炎和促消退作用。这些促消退介质作为特定受体的激动剂发挥作用。哮喘是一种不可治愈的慢性气道炎症性疾病,具有非消退性特征。虽然在哮喘发生过程中会产生促消退介质,但它们的产生缺陷与疾病严重程度有关,这表明哮喘的病理生物学可能部分是由于气道炎症消退受损所致。

相似文献

1
Resolution of inflammation in asthma.哮喘炎症的消退。
Clin Chest Med. 2012 Sep;33(3):559-70. doi: 10.1016/j.ccm.2012.06.006. Epub 2012 Jul 25.
2
Towards targeting resolution pathways of airway inflammation in asthma.针对哮喘气道炎症的解决途径。
Pharmacol Ther. 2018 Jun;186:98-113. doi: 10.1016/j.pharmthera.2018.01.004. Epub 2018 Jan 20.
8
Fatty acids, inflammation, and asthma.脂肪酸、炎症与哮喘。
J Allergy Clin Immunol. 2014 May;133(5):1255-64. doi: 10.1016/j.jaci.2013.12.1087. Epub 2014 Mar 7.
9
10
Inflammation resolution in environmental pulmonary health and morbidity.环境肺健康与发病中的炎症解决。
Toxicol Appl Pharmacol. 2022 Aug 15;449:116070. doi: 10.1016/j.taap.2022.116070. Epub 2022 May 23.

引用本文的文献

7
Inflammation resolution in environmental pulmonary health and morbidity.环境肺健康与发病中的炎症解决。
Toxicol Appl Pharmacol. 2022 Aug 15;449:116070. doi: 10.1016/j.taap.2022.116070. Epub 2022 May 23.
9
Altered tissue specialized pro-resolving mediators in chronic rhinosinusitis.慢性鼻-鼻窦炎组织中改变的组织特异性促解决介质。
Prostaglandins Leukot Essent Fatty Acids. 2021 Jan;164:102218. doi: 10.1016/j.plefa.2020.102218. Epub 2020 Nov 26.
10
Granulocyte-targeted therapies for airway diseases.靶向粒细胞的气道疾病治疗策略。
Pharmacol Res. 2020 Jul;157:104881. doi: 10.1016/j.phrs.2020.104881. Epub 2020 May 4.

本文引用的文献

2
Novel proresolving aspirin-triggered DHA pathway.新型促消退的阿司匹林触发的DHA途径。
Chem Biol. 2011 Aug 26;18(8):976-87. doi: 10.1016/j.chembiol.2011.06.008.
10
Nonresolving inflammation.未解决的炎症。
Cell. 2010 Mar 19;140(6):871-82. doi: 10.1016/j.cell.2010.02.029.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验